Clinical Trials
Showing trials with last updates posted in 2025.
17
Participants
A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-25
Completion:
2025-11-20
Conditions
Plaque Psoriasis
Interventions
DRUG
No Results Yet
700
Participants
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-24
Completion:
2027-10-31
Conditions
Miscarriage
Early Pregnancy Loss
No Results Yet
15
Participants
A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-12
Completion:
2024-06-04
Conditions
Multiple Myeloma
Interventions
DRUG
148
Participants
Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2025-01-01
Completion:
2026-06-30
Conditions
Osteoarthritis, Knee
Interventions
BIOLOGICAL
OTHER
No Results Yet
69
Participants
Study to Assess SLN124 in Patients With Polycythemia Vera
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-01-26
Completion:
2026-09-30
Conditions
Polycythemia Vera
Interventions
DRUG
No Results Yet
10800
Participants
Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-19
Completion:
2026-06-01
Conditions
E-cigarette Use
Interventions
BEHAVIORAL
No Results Yet
708
Participants
DIStal Versus COnventional Radial Access for COMPLEX Large-bore Percutaneous Coronary Intervention
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-08-31
Completion:
2026-06-01
Conditions
Vascular Access Site Occlusion
Interventions
PROCEDURE
No Results Yet
30
Participants
Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-09-30
Completion:
2026-06-30
Conditions
Stroke
Interventions
DEVICE
No Results Yet
100
Participants
Observational Study of Ketamine Infusions for the Treatment of Chronic Pain
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2022-06-01
Completion:
2026-12-31
Conditions
Chronic Pain
Interventions
DRUG
No Results Yet
92
Participants
A Care Empowerment Program Using Virtual Reality for Family Caregivers of People With Dementia
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-01
Completion:
2023-07-01
Conditions
Dementia Family Caregiver
Interventions
OTHER
No Results Yet
24
Participants
Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-11
Completion:
2025-12-12
Conditions
Furmonertinib
EGFR-mutation
NSCLC
Brain Metastases
Interventions
DRUG
No Results Yet
43
Participants
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-29
Completion:
2024-10-22
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DRUG
30
Participants
Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-03-27
Completion:
2026-03-01
Conditions
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Interventions
DRUG
BIOLOGICAL
PROCEDURE
No Results Yet
120
Participants
PTSD Treatment for Incarcerated Men and Women: WPP
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2024-01-04
Completion:
2026-01-31
Conditions
PTSD
Interventions
BEHAVIORAL
No Results Yet
17
Participants
TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-08
Completion:
2024-05-28
Conditions
Malnutrition
Interventions
DIETARY_SUPPLEMENT
No Results Yet
24
Participants
A Study in Healthy People to Compare 2 Different Formulations of BI 1015550 Taken With or Without Food
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-15
Completion:
2022-09-30
Conditions
Healthy
Interventions
DRUG
450
Participants
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2024-12-11
Completion:
2028-01-30
Conditions
Candidemia
Candidiasis, Invasive
Interventions
DRUG
No Results Yet
191
Participants
Targeting Inflammation for Endometrial Cancer Prevention
Study Type:
OBSERVATIONAL
Last Updated:
2025-12-19
Start Date:
2021-12-01
Completion:
2026-12-31
Conditions
Endometrial Carcinoma
Interventions
PROCEDURE
OTHER
No Results Yet
418
Participants
A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-05
Completion:
2024-01-03
Conditions
Advanced or Metastatic Non-small Cell Lung Cancer
Interventions
DRUG
No Results Yet
48
Participants
Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-06-01
Completion:
2024-04-01
Conditions
Multiple Sclerosis
Interventions
OTHER
No Results Yet
398
Participants
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-06-07
Completion:
2026-11-30
Conditions
Gastric Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Pancreatic Adenocarcinoma
Interventions
DRUG
No Results Yet
40
Participants
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-05-12
Completion:
2026-01-31
Conditions
Sickle Cell Anemia
Beta Thalassemia
Interventions
RADIATION
DRUG
BIOLOGICAL
No Results Yet
25
Participants
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-02-23
Completion:
2030-11-30
Conditions
Lymphadenopathy Retroperitoneal
Stage II Testicular Seminoma
Interventions
PROCEDURE
No Results Yet
399
Participants
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-10
Completion:
2024-08-05
Conditions
SGA, Turner Syndrome, Noonan Syndrome, ISS
Interventions
DRUG
No Results Yet
262
Participants
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-04-11
Completion:
2028-03-30
Conditions
Urinary Bladder Neoplasms
Receptors, Fibroblast Growth Factor
Interventions
DRUG
No Results Yet
40
Participants
An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2021-11-13
Completion:
2026-06-30
Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG
No Results Yet
55
Participants
Feasibility of a Train-the-Trainer Delivered Exercise Intervention in Firefighters
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2023-04-01
Completion:
2025-09-26
Conditions
Firefighter
High Intensity Interval Training
Interventions
BEHAVIORAL
No Results Yet
158
Participants
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-03-22
Completion:
2027-08-31
Conditions
Neoplasms
Interventions
DRUG
No Results Yet
25
Participants
Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-09-08
Completion:
2025-01-30
Conditions
Fallopian Tube Endometrioid Adenocarcinoma
Fallopian Tube High Grade Serous Adenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Ovarian High Grade Serous Adenocarcinoma
Primary Peritoneal Endometrioid Adenocarcinoma
Primary Peritoneal High Grade Serous Adenocarcinoma
Stage III Fallopian Tube Cancer AJCC v8
Stage III Ovarian Cancer AJCC v8
Stage III Primary Peritoneal Cancer AJCC v8
Stage IV Fallopian Tube Cancer AJCC v8
Stage IV Ovarian Cancer AJCC v8
Stage IV Primary Peritoneal Cancer AJCC v8
Unresectable Fallopian Tube Endometrioid Adenocarcinoma
Unresectable Fallopian Tube High Grade Serous Adenocarcinoma
Unresectable Ovarian Endometrioid Adenocarcinoma
Unresectable Ovarian High Grade Serous Adenocarcinoma
Unresectable Primary Peritoneal Endometrioid Adenocarcinoma
Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma
Interventions
PROCEDURE
DRUG
164
Participants
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-11
Completion:
2027-04-30
Conditions
Advanced Cancer
Interventions
DRUG
No Results Yet
283
Participants
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-10-20
Completion:
2033-09-30
Conditions
Relapsed/Refractory Multiple Myeloma
Interventions
DRUG
No Results Yet
528
Participants
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-06-23
Completion:
2025-12-02
Conditions
Aneurysm Cerebral
Endovascular Procedures
Interventions
DRUG
No Results Yet
70
Participants
A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-15
Completion:
2026-06-30
Conditions
Metastatic Pancreatic Adenocarcinoma
Interventions
DRUG
No Results Yet
304
Participants
The Lifestyle Education About Prediabetes (Leap) Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-03-20
Completion:
2025-11-14
Conditions
PreDiabetes
Interventions
BEHAVIORAL
No Results Yet
60
Participants
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-02-04
Completion:
2029-03-28
Conditions
Early-Onset Alzheimer Disease
Interventions
DRUG
No Results Yet
1350
Participants
Drug-Coated Balloon in Patients With High Bleeding Risk
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-29
Completion:
2027-11-30
Conditions
Coronary Artery Disease
Interventions
PROCEDURE
No Results Yet
45
Participants
PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-11-07
Completion:
2027-12-31
Conditions
HPV
Interventions
BIOLOGICAL
No Results Yet
74
Participants
VIBRANT: VIB4920 for Active Lupus Nephritis
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-05-16
Completion:
2026-08-31
Conditions
Lupus Nephritis
Interventions
DRUG
No Results Yet
25
Participants
NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-07-22
Completion:
2026-07-01
Conditions
Chronic Granulomatous Disease
Infection
Interventions
BIOLOGICAL
No Results Yet
68
Participants
A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole
Study Type:
INTERVENTIONAL
Last Updated:
2025-12-19
Start Date:
2022-08-03
Completion:
2025-11-07
Conditions
Candidiasis, Invasive
Candidemia
Interventions
DRUG
No Results Yet
Showing 40 trials per page